Kabra Drugs Ltd

Kabra Drugs Ltd Q2 2025: Revenue Jumps, Profit Swings to Positive 📈

- Total assets as of September 30, 2025: ₹5,450.18 lakhs (current assets: ₹5,319.87 lakhs).

- Cash & equivalents dropped to ₹1,160.99 lakhs (from ₹2,129.93 lakhs in March 2025).

- Q2 revenue from operations: ₹1,976.40 lakhs (vs. ₹715.00 lakhs in Q1).

- Total income for Q2: ₹1,994.27 lakhs (other income: ₹17.87 lakhs).

- Half-year total income (Sept 2025): ₹2,710.88 lakhs.

- Q2 profit before tax: ₹220.51 lakhs (vs. Q1 loss of ₹49.98 lakhs).

- Q2 net profit after tax: ₹183.68 lakhs (vs. Q1 net loss of ₹49.98 lakhs).

- Q2 EPS: ₹0.77 (vs. Q1 loss per share of ₹0.21).